Medicus Pharma (NASDAQ:MDCX) announced a warrant inducement agreement allowing immediate exercise of its Series A and B Warrants at a reduced price of $1.92, raising approximately $5.1M from 2.68M shares.
In return, the company will issue unregistered Series C and D Warrants for 4.02M shares at $2 each, exercisable over 5.5 years.
Maxim Group LLC is the exclusive financial advisor, and the company will file SEC registration for the New Warrants’ shares. Closing is expected around Dec. 5, 2025.